AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vildacart-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Medi Cartel

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildacart-M 50/500 Tablet

Vildacart-M 50/500 tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications, such as renal impairment and vision loss, and may lower the risk of cardiovascular events like stroke or heart attack. Vildacart-M 50/500 may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing is crucial for maximum benefit; discontinuation should only occur under medical supervision. Effective blood sugar control reduces the likelihood of future complications. Continued adherence to your doctor's dietary and exercise plan is essential for successful diabetes management, as lifestyle factors significantly influence blood sugar control. Common adverse effects include nausea, vomiting, diarrhea, indigestion, headache, pharyngitis, asthenia, gastroesophageal reflux, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its symptoms and management. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before use. Potential drug interactions necessitate disclosing all current medications to your doctor. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood sugar levels throughout treatment.

Primary Ingredients of Vildacart-M 50/500 Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Vildacart-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Vildacart-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Vildacart-M 50/500 Tablet with a meal.

Common Side effects of Vildacart-M 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildacart-M 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildacart-M 50/500 Tablet with a meal.

How Vildacart-M 50/500 Tablet works:

Vildacart-M 50/500 tablets contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildacart-M 50/500 Tablet and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildacart-M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against potential dangers prior to prescription. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and the use of Vildacart-M 50/500 tablets are likely incompatible. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildacart-M 50/500 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Vildacart-M 50/500 Tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Vildacart-M 50/500 Tablet :

Should you forget a Vildacart-M 50/500 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Vildacart-M 50/500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildacart-M 50/500 Tablet

Vildacart-M 50/500 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may occur, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Regular blood glucose monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildacart-M 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vildacart-M 50/500 Tablet is contraindicated in patients with allergies to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Vildacart-M 50/500 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin release. This combination is contraindicated for individuals under 18.
Vildacart-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vildacart-M 50/500 Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildacart-M 50/500 Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent side effects to your physician.
Vildacart-M 50/500 Tablet
105
MRP 122
14% off